Rifampicin Reduces Plasma Concentrations of Moxifloxacin in Patients with Tuberculosis

BACKGROUND: The long duration of the current tuberculosis (TB) treatment is demanding and warrants the development of new drugs. Moxifloxacin shows promising results and may be combined with rifampicin to shorten the duration of TB treatment. Rifampicin induces the phase II metabolic enzymes that ar... View More